We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$487M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$48.2M
3
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.4M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$28.9M
5
MSFT icon
Microsoft
MSFT
+$27.7M

Top Sells

Rank Stock Value
1
VXX icon
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
+$51.8M
2
VOO icon
Vanguard S&P 500 ETF
VOO
+$38.5M
3
SOXL icon
Direxion Daily Semiconductor Bull 3X ETF
SOXL
+$32.6M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$21M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$16.6M

Sector Composition

Rank Sector Weight
1 Technology 6.25%
2 Industrials 4.6%
3 Consumer Discretionary 4.31%
4 Healthcare 4.26%
5 Financials 3.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTMD icon
2151
Utah Medical Products
UTMD
$230M
$311K ﹤0.01%
3,891
+2,310
+146% +$192K
CCRD
2152
DELISTED
CoreCard
CCRD
$310K ﹤0.01%
7,944
+5,892
+287% +$206K
HCKT icon
2153
Hackett Group
HCKT
$277M
$310K ﹤0.01%
27,715
+22,909
+477% +$296K
MCY icon
2154
Mercury Insurance
MCY
$5.81B
$310K ﹤0.01%
7,488
+5,047
+207% +$217K
ARDX icon
2155
Ardelyx
ARDX
$1.01B
$309K ﹤0.01%
58,816
+33,863
+136% +$204K
SM icon
2156
SM Energy
SM
$7.71B
$309K ﹤0.01%
194,342
+179,823
+1,239% +$502K
TER icon
2157
Teradyne
TER
$64.2B
$309K ﹤0.01%
3,888
-43,238
-92% -$3.67M
BF.B icon
2158
Brown-Forman Class B
BF.B
$12.9B
$308K ﹤0.01%
4,090
-4,883
-54% -$350K
NRG icon
2159
NRG Energy
NRG
$25.2B
$308K ﹤0.01%
10,003
-16,455
-62% -$544K
RAPT
2160
DELISTED
RAPT Therapeutics
RAPT
$308K ﹤0.01%
1,194
+1,073
+887% +$238K
TVRD
2161
Tvardi Therapeutics
TVRD
$22.1M
$308K ﹤0.01%
674
+501
+290% +$291K
CTRN icon
2162
Citi Trends
CTRN
$621M
$307K ﹤0.01%
12,274
+9,502
+343% +$189K
MBWM icon
2163
Mercantile Bank Corp
MBWM
$1.06B
$307K ﹤0.01%
17,068
+14,330
+523% +$300K
OLP
2164
One Liberty Properties
OLP
$537M
$307K ﹤0.01%
18,803
+14,534
+340% +$259K
ZYXI
2165
DELISTED
Zynex
ZYXI
$307K ﹤0.01%
19,392
+15,479
+396% +$261K
AUD
2166
DELISTED
Audacy, Inc.
AUD
$307K ﹤0.01%
190,202
+87,992
+86% +$132K
SBNY
2167
DELISTED
Signature Bank
SBNY
$307K ﹤0.01%
3,699
-5,828
-61% -$580K
CRAI icon
2168
CRA International
CRAI
$1.07B
$306K ﹤0.01%
8,165
+6,844
+518% +$283K
FFIC
2169
DELISTED
Flushing Financial
FFIC
$306K ﹤0.01%
29,120
+23,781
+445% +$270K
GRMN
2170
Garmin
GRMN
$60.2B
$306K ﹤0.01%
3,226
+827
+34% +$82.7K
GLIBA
2171
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$306K ﹤0.01%
3,739
+3,717
+16,895% +$293K
GWW icon
2172
W.W. Grainger
GWW
$62.2B
$305K ﹤0.01%
855
+219
+34% +$75.5K
KALA icon
2173
KALA BIO
KALA
$17.9M
$305K ﹤0.01%
16
+14
+700% +$322K
RSPS icon
2174
Invesco S&P 500 Equal Weight Consumer Staples ETF
RSPS
$248M
$305K ﹤0.01%
10,675
-23,365
-69% -$669K
RBCAA icon
2175
Republic Bancorp
RBCAA
$1.92B
$304K ﹤0.01%
10,794
+8,582
+388% +$264K
85 86
87
88 89

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 12% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.